| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | MAGED1 SERTAD2 CREBBP PPARGC1A KMT2C KMT2D CIITA TADA2B HELZ2 MED13 WWC1 | 4.55e-05 | 303 | 165 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | latrotoxin receptor activity | 6.79e-05 | 2 | 165 | 2 | GO:0016524 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.67e-04 | 187 | 165 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NANOGP8 PRAMEF5 MAGED1 NANOG SERTAD2 GRB10 YTHDC2 EWSR1 ATG2A CREBBP NLRP3 IQGAP1 PPARGC1A KMT2C KMT2D CIITA TADA2B HELZ2 MED13 WWC1 TNS3 PRAMEF6 | 2.31e-04 | 1160 | 165 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NANOGP8 PRAMEF5 MAGED1 NANOG SERTAD2 GRB10 NCBP1 YTHDC2 EWSR1 ATG2A CREBBP NLRP3 IQGAP1 PPARGC1A KMT2C KMT2D CIITA TADA2B HELZ2 CNOT1 MED13 WWC1 TNS3 PRAMEF6 | 3.29e-04 | 1356 | 165 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 4.03e-04 | 4 | 165 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 4.03e-04 | 4 | 165 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 4.03e-04 | 4 | 165 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 4.03e-04 | 4 | 165 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 4.03e-04 | 4 | 165 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | transcription factor binding | NANOGP8 PRAMEF5 NANOG PPP1R13B RELA NR4A1 CREBBP NLRP3 CRY2 PPARGC1A ZBTB7A CIITA CNOT1 MED13 PRAMEF6 CREB3 | 5.22e-04 | 753 | 165 | 16 | GO:0008134 |
| GeneOntologyMolecularFunction | pheromone binding | 6.68e-04 | 5 | 165 | 2 | GO:0005550 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 9.96e-04 | 6 | 165 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 9.96e-04 | 6 | 165 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | PRAMEF5 RELA NR4A1 CREBBP NLRP3 CRY2 PPARGC1A ZBTB7A CIITA CNOT1 MED13 PRAMEF6 CREB3 | 1.12e-03 | 582 | 165 | 13 | GO:0140297 |
| Domain | OLF | 1.63e-04 | 13 | 159 | 3 | PF02191 | |
| Domain | OLF | 1.63e-04 | 13 | 159 | 3 | PS51132 | |
| Domain | Olfac-like_dom | 1.63e-04 | 13 | 159 | 3 | IPR003112 | |
| Domain | OLF | 1.63e-04 | 13 | 159 | 3 | SM00284 | |
| Domain | Latrophilin | 2.15e-04 | 3 | 159 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 2.15e-04 | 3 | 159 | 2 | IPR003334 | |
| Domain | von_Ebner_gland | 2.15e-04 | 3 | 159 | 2 | IPR002450 | |
| Domain | ARM-type_fold | TNPO1 RIPOR2 DOCK8 UBR4 TOGARAM1 NCBP1 PSMD5 HUWE1 VIRMA DAAM2 | 6.66e-04 | 339 | 159 | 10 | IPR016024 |
| Domain | FYrich_C | 7.08e-04 | 5 | 159 | 2 | IPR003889 | |
| Domain | FYrich_N | 7.08e-04 | 5 | 159 | 2 | IPR003888 | |
| Domain | FYRC | 7.08e-04 | 5 | 159 | 2 | SM00542 | |
| Domain | FYRN | 7.08e-04 | 5 | 159 | 2 | SM00541 | |
| Domain | EXOC3/Sec6 | 7.08e-04 | 5 | 159 | 2 | IPR010326 | |
| Domain | VWA_N | 7.08e-04 | 5 | 159 | 2 | IPR013608 | |
| Domain | VWA_N | 7.08e-04 | 5 | 159 | 2 | PF08399 | |
| Domain | Gal_Lectin | 7.08e-04 | 5 | 159 | 2 | PF02140 | |
| Domain | Sec6 | 7.08e-04 | 5 | 159 | 2 | PF06046 | |
| Domain | GPCR_2_latrophilin | 7.08e-04 | 5 | 159 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 7.08e-04 | 5 | 159 | 2 | IPR000922 | |
| Domain | FYRN | 7.08e-04 | 5 | 159 | 2 | PF05964 | |
| Domain | FYRC | 7.08e-04 | 5 | 159 | 2 | PF05965 | |
| Domain | FYRC | 7.08e-04 | 5 | 159 | 2 | PS51543 | |
| Domain | FYRN | 7.08e-04 | 5 | 159 | 2 | PS51542 | |
| Domain | SUEL_LECTIN | 7.08e-04 | 5 | 159 | 2 | PS50228 | |
| Pubmed | TNPO1 FLNB COPA SPTAN1 UBR4 NOL6 NCBP1 YTHDC2 EWSR1 HUWE1 VIRMA IQGAP1 DHX15 SART1 FASN PHF3 HELZ2 EIF5B CNOT1 ZMYM3 SYNCRIP | 7.01e-12 | 653 | 166 | 21 | 22586326 | |
| Pubmed | PAK4 LARS1 SERTAD2 E2F3 CACHD1 ATG2A IQGAP1 ARHGAP4 KMT2C SYNJ2 UNK ADGRL2 CARNS1 DNMBP ESPL1 CNOT1 MED13 SMG6 | 9.85e-11 | 529 | 166 | 18 | 14621295 | |
| Pubmed | TNPO1 PITHD1 FLNB COPA PAK4 LARS1 MPDZ YTHDC2 LRRC59 CACHD1 IQGAP1 DHX15 RABL6 FASN PTPN13 KIDINS220 EIF5B ADGRL2 CNOT1 SYNCRIP | 2.25e-10 | 708 | 166 | 20 | 39231216 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TNPO1 MAGED1 COPA SPTAN1 PAK4 YTHDC2 LRRC59 DHX15 SART1 PTPN13 SYNJ2 PHF3 TADA2B AGFG1 EIF5B UNK DNMBP ESPL1 CNOT1 TNS3 | 3.32e-10 | 724 | 166 | 20 | 36232890 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | COPA SPTAN1 NELFB YTHDC2 HUWE1 VIRMA IQGAP1 SART1 ZBTB7A FASN KMT2D MAP1S PHF3 HELZ2 EIF5B UNK DNMBP ESPL1 MED13 ZMYM3 | 1.05e-09 | 774 | 166 | 20 | 15302935 |
| Pubmed | PITHD1 FLNB MAGED1 COPA SPTAN1 UBR4 LARS1 FUZ CHD9 NCBP1 E2F3 PSMD5 EWSR1 CACHD1 HUWE1 TF CREBBP IQGAP1 PTPN13 MAP1S LRP1 CCDC15 DAAM2 SNTA1 MED13 | 2.57e-09 | 1285 | 166 | 25 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UBR4 GRB10 ADGRL1 ATG2A HUWE1 COMTD1 FAAP100 PLCD3 RABL6 ESRP2 ZGPAT KMT2C FASN KMT2D MAP1S HELZ2 HERC1 DNMBP ESPL1 ALOX5 MED13 CREB3 SMG6 | 3.38e-09 | 1105 | 166 | 23 | 35748872 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TNPO1 FLNB GINS3 COPA SPTAN1 UBR4 LARS1 NELFB NCBP1 PSMD5 RELA HUWE1 IQGAP1 DHX15 RABL6 CDAN1 FASN MAP1S AGFG1 EIF5B GNAI3 HERC1 DNMBP CNOT1 TNS3 SYNCRIP | 6.86e-09 | 1455 | 166 | 26 | 22863883 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TNPO1 FLNB COPA DSG3 SPTAN1 ECD NOL6 LARS1 NCBP1 YTHDC2 EWSR1 LRRC59 VIRMA IQGAP1 DHX15 PLEK2 SART1 FASN PHF3 HELZ2 EIF5B GNAI3 SYNCRIP CDK7 | 7.94e-09 | 1257 | 166 | 24 | 36526897 |
| Pubmed | FLNB COPA UBR4 LARS1 NCBP1 PSMD5 EWSR1 LRRC59 ITGAV IQGAP1 DHX15 FASN KIDINS220 AGFG1 EIF5B GNAI3 CNOT1 SYNCRIP | 9.50e-09 | 707 | 166 | 18 | 19738201 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MAGED1 COPA CARMIL3 SPTAN1 UBR4 MPDZ YTHDC2 TF IQGAP1 RABL6 CDAN1 KCNMA1 EIF5B UNK SYNCRIP | 1.05e-08 | 475 | 166 | 15 | 31040226 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TNPO1 FLNB ECD UBR4 MPDZ YTHDC2 HUWE1 FAAP100 TF FASN KIDINS220 LRP1 GNAI3 PIPSL ADGRL2 ESPL1 SNTA1 WWC1 TNS3 SYNCRIP | 4.85e-08 | 974 | 166 | 20 | 28675297 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB COPA SPTAN1 UBR4 LARS1 NCBP1 PSMD5 EWSR1 LRRC59 HUWE1 IQGAP1 DHX15 FASN EIF5B DAAM2 BRSK1 CNOT1 SYNCRIP | 7.02e-08 | 807 | 166 | 18 | 30575818 |
| Pubmed | FLNB COPA SPTAN1 E2F3 HUWE1 CREBBP FASN HELZ2 ADGRL2 CNOT1 TNS3 CREB3 | 7.69e-08 | 332 | 166 | 12 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | FLNB COPA SPTAN1 UBR4 LARS1 HUWE1 IQGAP1 SART1 FASN PHF3 ZMYM3 SYNCRIP | 7.69e-08 | 332 | 166 | 12 | 32786267 |
| Pubmed | TNPO1 FLNB COPA SPTAN1 UBR4 LARS1 NELFB NCBP1 LRRC59 HUWE1 IQGAP1 DHX15 FASN EIF5B CNOT1 SYNCRIP | 8.11e-08 | 638 | 166 | 16 | 33239621 | |
| Pubmed | FLNB COPA SPTAN1 LARS1 PSMD5 IQGAP1 DHX15 FASN EIF5B CNOT1 ZMYM3 SYNCRIP | 8.21e-08 | 334 | 166 | 12 | 30425250 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNB CDC42EP4 SPTAN1 PAK4 PPP1R13B LRRC59 IQGAP1 FASN KIDINS220 STXBP6 SYNJ2 AGFG1 PPP1R37 PLSCR3 ADGRL2 | 1.01e-07 | 565 | 166 | 15 | 25468996 |
| Pubmed | TNPO1 FLNB COPA SPTAN1 LARS1 CHD9 EWSR1 LRRC59 IQGAP1 DHX15 FASN EIF5B CNOT1 SYNCRIP | 1.25e-07 | 494 | 166 | 14 | 26831064 | |
| Pubmed | TNPO1 TCF7 COPA SPTAN1 LARS1 CHD9 NCBP1 EWSR1 LRRC59 HUWE1 IQGAP1 DHX15 SART1 FASN PHF3 EIF5B GNAI3 MED13 WWC1 TNS3 SYNCRIP ADSS1 | 1.39e-07 | 1247 | 166 | 22 | 27684187 | |
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 37012455 | ||
| Pubmed | MAGED1 NOL6 MPDZ YTHDC2 RELA COMTD1 VIRMA IQGAP1 PLCD3 ZGPAT KMT2C ZBTB7A PTPN13 KIDINS220 PHF3 TADA2B HELZ2 EIF5B UNK DNMBP MED13 ZMYM3 SMG6 CDK7 | 2.07e-07 | 1497 | 166 | 24 | 31527615 | |
| Pubmed | TNPO1 FLNB RIPOR2 PRAMEF5 PAK4 PABPN1L HUWE1 ITGA9 PPCS PPARGC1A KMT2C PTPN13 KCNJ3 EXOC3L4 EXOC3L1 GNAI3 HERC1 ESPL1 CNOT1 PRAMEF6 | 2.69e-07 | 1084 | 166 | 20 | 11544199 | |
| Pubmed | FLNB COPA DOCK8 SPTAN1 LARS1 BRSK2 ADGRL1 OPA3 YTHDC2 EWSR1 LRRC59 VIRMA TF IQGAP1 DHX15 FASN KIDINS220 MAP1S BRSK1 CNOT1 SNTA1 CACNA2D3 SYNCRIP | 3.65e-07 | 1431 | 166 | 23 | 37142655 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 28398509 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MAGED1 NOL6 PSMD5 YTHDC2 EWSR1 HUWE1 VIRMA RABL6 SART1 PTPN13 KIDINS220 SYNCRIP | 5.64e-07 | 400 | 166 | 12 | 35013556 |
| Pubmed | RIPOR2 STXBP5 GRB10 ADGRL1 VIRMA LRFN2 KIDINS220 PHF3 SEL1L3 BRINP2 DAAM2 ZMYM3 | 6.77e-07 | 407 | 166 | 12 | 12693553 | |
| Pubmed | RIPOR2 CDC42EP4 SPTAN1 PAK4 PPP1R13B ADGRL1 RELA CREBBP ZGPAT DES KMT2C SYNJ2 AGFG1 | 6.85e-07 | 486 | 166 | 13 | 20936779 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | COPA UBR4 LARS1 RELA HUWE1 FAAP100 CREBBP SART1 ESRP2 DES FASN KMT2D LRP1 EIF5B CCDC15 ADGRL2 ZMYM3 | 8.42e-07 | 857 | 166 | 17 | 25609649 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 COPA DOCK8 SPTAN1 PAK4 NCBP1 YTHDC2 HUWE1 RNF17 IQGAP1 SART1 FASN CNOT1 SYNCRIP | 8.89e-07 | 582 | 166 | 14 | 20467437 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.28e-06 | 221 | 166 | 9 | 29991511 | |
| Pubmed | 1.65e-06 | 169 | 166 | 8 | 31462741 | ||
| Pubmed | MAGED1 DOCK8 SPTAN1 PAK4 NELFB PPP1R13B MPDZ PTPN13 MAP1S UNK CNOT1 WWC1 | 1.75e-06 | 446 | 166 | 12 | 24255178 | |
| Pubmed | FLNB COPA SPTAN1 UBR4 EWSR1 LRRC59 IQGAP1 DHX15 SART1 ZGPAT KMT2C FASN KMT2D GNAI3 SYNCRIP | 1.82e-06 | 711 | 166 | 15 | 33022573 | |
| Pubmed | TNPO1 GINS3 COPA UBR4 NELFB CHD9 NCBP1 LRRC59 VIRMA CREBBP IQGAP1 DHX15 SART1 FASN PHF3 EIF5B MED13 CDK7 | 1.91e-06 | 1014 | 166 | 18 | 32416067 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB COPA SPTAN1 UBR4 NOL6 LARS1 PSMD5 HUWE1 CREBBP IQGAP1 DHX15 PLEK2 PLCD3 SART1 ZGPAT FASN PPP1R37 EIF5B ZMYM3 TNS3 SYNCRIP | 2.13e-06 | 1353 | 166 | 21 | 29467282 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CDC42EP4 STXBP5 PAK4 ITGAV IQGAP1 PTPN13 KIDINS220 GYPC DAAM2 GNAI3 PLSCR3 | 2.21e-06 | 377 | 166 | 11 | 38117590 |
| Pubmed | 2.42e-06 | 80 | 166 | 6 | 35803934 | ||
| Pubmed | TNPO1 COPA SPTAN1 PAK4 NOL6 LARS1 LRRC59 HUWE1 DHX15 FASN GNAI3 SYNCRIP | 2.58e-06 | 463 | 166 | 12 | 34901782 | |
| Pubmed | 2.61e-06 | 241 | 166 | 9 | 23125841 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PMS2P2 ZNF704 FLNB GRB10 ADGRL1 CHD9 E2F3 HUWE1 CREBBP KMT2C ZBTB7A PTPN13 LRFN2 KIDINS220 SYNJ2 KCNJ3 SEL1L3 KCNMA1 LRP1 CNOT1 SMG6 ADSS1 | 2.66e-06 | 1489 | 166 | 22 | 28611215 |
| Pubmed | 3.38e-06 | 131 | 166 | 7 | 28031328 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB MAGED1 SPTAN1 ECD LARS1 HUWE1 IQGAP1 DHX15 SART1 FASN EIF5B SYNCRIP | 3.50e-06 | 477 | 166 | 12 | 31300519 |
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 29547901 | ||
| Pubmed | 3.74e-06 | 322 | 166 | 10 | 26514267 | ||
| Pubmed | TNPO1 FLNB COPA SPTAN1 UBR4 LARS1 RNF149 LRRC59 ITGAV DHX15 SART1 FASN KIDINS220 MAP1S GCAT EIF5B GNAI3 CNOT1 SYNCRIP CDK7 | 4.19e-06 | 1297 | 166 | 20 | 33545068 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLNB COPA SPTAN1 EWSR1 LRRC59 IQGAP1 DHX15 PLCD3 DES FASN EIF5B GNAI3 SYNCRIP | 4.76e-06 | 580 | 166 | 13 | 35676659 |
| Pubmed | TCF7 MAGED1 COPA SPTAN1 UBR4 LARS1 PPP1R13B E2F3 RELA EWSR1 LRRC59 CREBBP KMT2C ZBTB7A KMT2D TADA2B UNK HERC1 CNOT1 ZMYM3 SYNCRIP | 4.97e-06 | 1429 | 166 | 21 | 35140242 | |
| Pubmed | MAGED1 PPP1R13B YTHDC2 RABL6 PTPN13 KIDINS220 PLSCR3 DNMBP CNOT1 | 5.31e-06 | 263 | 166 | 9 | 34702444 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.68e-06 | 344 | 166 | 10 | 30333137 | |
| Pubmed | 7.39e-06 | 274 | 166 | 9 | 34244482 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | TNPO1 COPA SPTAN1 LARS1 NCBP1 EWSR1 LRRC59 HUWE1 VIRMA TF IQGAP1 SART1 EIF5B | 7.75e-06 | 607 | 166 | 13 | 39147351 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | COPA UBR4 NOL6 LARS1 NELFB PSMD5 YTHDC2 HUWE1 VIRMA IQGAP1 FASN MAP1S GNAI3 CNOT1 | 7.95e-06 | 704 | 166 | 14 | 29955894 |
| Pubmed | 7.96e-06 | 209 | 166 | 8 | 36779422 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TNPO1 FLNB NCBP1 YTHDC2 EWSR1 VIRMA DHX15 SART1 ESRP2 FASN HELZ2 EIF5B UNK CNOT1 SYNCRIP | 8.35e-06 | 807 | 166 | 15 | 22681889 |
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 18223644 | ||
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 16801560 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TNPO1 FLNB COPA NOL6 LARS1 NCBP1 YTHDC2 EWSR1 LRRC59 HUWE1 IQGAP1 DHX15 SART1 FASN EIF5B CNOT1 SYNCRIP | 8.99e-06 | 1024 | 166 | 17 | 24711643 |
| Pubmed | 9.41e-06 | 101 | 166 | 6 | 9872452 | ||
| Pubmed | 1.04e-05 | 286 | 166 | 9 | 32041737 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TNPO1 FLNB MAGED1 COPA SPTAN1 UBR4 LARS1 MPDZ EWSR1 LRRC59 HUWE1 IQGAP1 DHX15 FASN AGFG1 EIF5B CNOT1 SYNCRIP | 1.06e-05 | 1149 | 166 | 18 | 35446349 |
| Pubmed | 1.11e-05 | 104 | 166 | 6 | 9205841 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | MAGED1 DSG3 POLM LARS1 YTHDC2 TF IQGAP1 KIDINS220 HELZ2 EIF5B GNAI3 C5 BRSK1 CNOT1 | 1.23e-05 | 732 | 166 | 14 | 34732716 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TNPO1 MAGED1 COPA OBP2A UBR4 LARS1 LRRC59 CACHD1 HUWE1 COG8 IQGAP1 FASN KIDINS220 ADGRL2 ESPL1 ZMYM3 | 1.26e-05 | 942 | 166 | 16 | 31073040 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNB COPA SPTAN1 NOL6 LARS1 EWSR1 LRRC59 IQGAP1 DHX15 PLCD3 SART1 FASN TADA2B EIF5B GNAI3 SYNCRIP | 1.38e-05 | 949 | 166 | 16 | 36574265 |
| Pubmed | 1.44e-05 | 298 | 166 | 9 | 30737378 | ||
| Pubmed | PITHD1 FLNB SPTAN1 UBR4 LARS1 YTHDC2 EWSR1 HUWE1 DHX15 SART1 FASN SYNCRIP | 1.48e-05 | 551 | 166 | 12 | 34728620 | |
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 24858485 | ||
| Pubmed | TNPO1 FLNB MAGED1 COPA SPTAN1 ECD UBR4 NOL6 LARS1 NCBP1 YTHDC2 LRRC59 HUWE1 IQGAP1 DHX15 FASN EIF5B ADGRL2 CNOT1 SYNCRIP | 1.92e-05 | 1440 | 166 | 20 | 30833792 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | TNPO1 MAGED1 NOL6 LPCAT4 NELFB RNF149 NCBP1 LRRC59 ITGAV VIRMA DHX15 SART1 FASN PHF3 LRP1 GNAI3 CNOT1 ZMYM3 | 1.95e-05 | 1203 | 166 | 18 | 29180619 |
| Pubmed | 2.05e-05 | 69 | 166 | 5 | 32238831 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12459554 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9548485 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19158360 | ||
| Pubmed | Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways. | 2.26e-05 | 2 | 166 | 2 | 27262946 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 35464766 | ||
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 2.26e-05 | 2 | 166 | 2 | 33824309 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25808902 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26937141 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 11207030 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31924266 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 29813070 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 2.26e-05 | 2 | 166 | 2 | 19415763 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9681993 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 32945392 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 10607840 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28967912 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20516639 | ||
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 2.26e-05 | 2 | 166 | 2 | 3123997 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 2939097 | ||
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 2.26e-05 | 2 | 166 | 2 | 27999180 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 38697949 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 36601880 | ||
| Pubmed | Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. | 2.26e-05 | 2 | 166 | 2 | 30307479 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28483418 | ||
| Pubmed | Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina. | 2.26e-05 | 2 | 166 | 2 | 26393668 | |
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 2.26e-05 | 2 | 166 | 2 | 11032406 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 2.26e-05 | 2 | 166 | 2 | 34156443 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12044155 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 10542243 | ||
| Interaction | KCNA3 interactions | TNPO1 PITHD1 FLNB COPA PAK4 LARS1 GRB10 MPDZ CHD9 YTHDC2 LRRC59 CACHD1 IQGAP1 DHX15 RABL6 KMT2C FASN PTPN13 KIDINS220 PHF3 EIF5B ADGRL2 CNOT1 SYNCRIP | 1.02e-07 | 871 | 160 | 24 | int:KCNA3 |
| Interaction | SIRT7 interactions | TNPO1 FLNB MAGED1 COPA SPTAN1 UBR4 NOL6 NCBP1 YTHDC2 EWSR1 HUWE1 VIRMA IQGAP1 DHX15 SART1 FASN PHF3 HELZ2 EIF5B CNOT1 ZMYM3 SYNCRIP | 1.10e-07 | 744 | 160 | 22 | int:SIRT7 |
| Interaction | BRCA1 interactions | TNPO1 FLNB COPA NANOG SPTAN1 UBR4 LARS1 NELFB PPP1R13B CHD9 RELA EWSR1 LRRC59 HUWE1 FAAP100 CREBBP IQGAP1 CRY2 DHX15 DES FASN EIF5B HERC1 BRSK1 CNOT1 ZMYM3 SYNCRIP CDK7 | 5.60e-07 | 1249 | 160 | 28 | int:BRCA1 |
| Interaction | ITGB3 interactions | 1.07e-06 | 170 | 160 | 10 | int:ITGB3 | |
| Interaction | KPNA6 interactions | 1.33e-06 | 174 | 160 | 10 | int:KPNA6 | |
| Interaction | USP9X interactions | TNPO1 MAGED1 NANOG UBR4 PAK4 GRB10 HUWE1 ASB15 VIRMA NLRP3 CRY2 FASN UNK BRSK1 WWC1 | 1.44e-06 | 422 | 160 | 15 | int:USP9X |
| Interaction | TOP3B interactions | SPTAN1 UBR4 LARS1 GRB10 ADGRL1 ATG2A HUWE1 COMTD1 FAAP100 IQGAP1 PLCD3 RABL6 ESRP2 ZGPAT KMT2C FASN KMT2D MAP1S HELZ2 UNK GNAI3 HERC1 DNMBP ESPL1 CNOT1 ALOX5 MED13 CREB3 SYNCRIP SMG6 | 1.48e-06 | 1470 | 160 | 30 | int:TOP3B |
| Interaction | USP14 interactions | FLNB COPA SPTAN1 LARS1 PSMD5 RELA CREBBP NLRP3 IQGAP1 DHX15 FASN EIF5B UNK CNOT1 ZMYM3 SYNCRIP | 1.86e-06 | 489 | 160 | 16 | int:USP14 |
| Interaction | PPARGC1A interactions | 4.02e-06 | 82 | 160 | 7 | int:PPARGC1A | |
| Interaction | STIP1 interactions | TNPO1 FLNB COPA DOCK8 SPTAN1 UBR4 LARS1 NELFB RNF149 NCBP1 EWSR1 LRRC59 HUWE1 VIRMA IQGAP1 DHX15 FASN MAP1S KCNMA1 EIF5B CNOT1 TNS3 SYNCRIP | 4.74e-06 | 1006 | 160 | 23 | int:STIP1 |
| Interaction | HDAC2 interactions | TNPO1 COPA NANOG LARS1 GRB10 RELA EWSR1 HUWE1 VIRMA CREBBP IQGAP1 DHX15 ZBTB7A CIITA HELZ2 AGFG1 UNK ESPL1 ZMYM3 SYNCRIP CDK7 | 5.14e-06 | 865 | 160 | 21 | int:HDAC2 |
| Interaction | VCL interactions | GINS3 SPTAN1 PAK4 RNF149 MPDZ EWSR1 LRRC59 VIRMA KIDINS220 UNK GNAI3 DNMBP | 6.10e-06 | 305 | 160 | 12 | int:VCL |
| Interaction | HDAC4 interactions | MAGED1 COPA CARMIL3 SPTAN1 UBR4 MPDZ YTHDC2 HUWE1 ASB15 VIRMA IQGAP1 RABL6 CDAN1 MAP1S CIITA KCNMA1 EIF5B UNK SYNCRIP | 7.38e-06 | 744 | 160 | 19 | int:HDAC4 |
| Interaction | DHX15 interactions | FLNB NOL6 LARS1 EWSR1 HUWE1 NR4A1 VIRMA IQGAP1 CRY2 DHX15 ZGPAT FASN UNK SYNCRIP CDK7 | 1.17e-05 | 502 | 160 | 15 | int:DHX15 |
| Interaction | MEX3A interactions | FLNB COPA SPTAN1 E2F3 HUWE1 CREBBP FASN HELZ2 UNK ADGRL2 CNOT1 TNS3 CREB3 | 1.25e-05 | 384 | 160 | 13 | int:MEX3A |
| Interaction | DIS3L2 interactions | 1.37e-05 | 39 | 160 | 5 | int:DIS3L2 | |
| Interaction | GRWD1 interactions | COPA SPTAN1 UBR4 GRB10 EWSR1 HUWE1 NR4A1 IQGAP1 DHX15 SART1 FASN KMT2D CNOT1 | 1.47e-05 | 390 | 160 | 13 | int:GRWD1 |
| Interaction | NOMO2 interactions | 1.76e-05 | 41 | 160 | 5 | int:NOMO2 | |
| Interaction | ERC1 interactions | 1.90e-05 | 187 | 160 | 9 | int:ERC1 | |
| Interaction | MGA interactions | 2.27e-05 | 240 | 160 | 10 | int:MGA | |
| Interaction | MIB1 interactions | MAGED1 E2F3 YTHDC2 LRRC59 VIRMA FASN PTPN13 SYNJ2 AGFG1 ADGRL2 CNOT1 | 2.47e-05 | 295 | 160 | 11 | int:MIB1 |
| Interaction | SREBF1 interactions | 2.68e-05 | 150 | 160 | 8 | int:SREBF1 | |
| Interaction | FOXM1 interactions | 3.33e-05 | 113 | 160 | 7 | int:FOXM1 | |
| Interaction | PPARG interactions | PAK4 RELA NR4A1 CREBBP DES PPARGC1A KMT2C KMT2D CIITA HELZ2 CNOT1 | 3.56e-05 | 307 | 160 | 11 | int:PPARG |
| Interaction | RAC1 interactions | TNPO1 FLNB CDC42EP4 DOCK8 STXBP5 SPTAN1 PAK4 RNF149 ADGRL1 LRRC59 HUWE1 ITGAV IQGAP1 ARHGAP4 FASN PTPN13 KIDINS220 SYNJ2 AGFG1 ADGRL2 DNMBP TNS3 | 3.60e-05 | 1063 | 160 | 22 | int:RAC1 |
| Interaction | PABPC1 interactions | FLNB NANOG LARS1 CHD9 NCBP1 LRRC59 NR4A1 VIRMA IQGAP1 DHX15 SART1 KMT2C FASN UNK CNOT1 SYNCRIP SMG6 | 4.25e-05 | 699 | 160 | 17 | int:PABPC1 |
| Interaction | KHDRBS1 interactions | COPA PPP1R13B EWSR1 VIRMA CREBBP CRY2 DHX15 ZBTB7A FASN KCNMA1 DNMBP SYNCRIP | 4.47e-05 | 373 | 160 | 12 | int:KHDRBS1 |
| Interaction | FN1 interactions | FLNB TCF7 LARS1 NCBP1 PSMD5 EWSR1 LRRC59 ITGAV VIRMA TF IQGAP1 MEP1B DHX15 FASN KIDINS220 EIF5B GNAI3 CNOT1 SYNCRIP | 4.49e-05 | 848 | 160 | 19 | int:FN1 |
| Interaction | PSMD6 interactions | FLNB NANOG LARS1 PSMD5 HUWE1 PPCS VIRMA IQGAP1 DHX15 SART1 FASN | 4.76e-05 | 317 | 160 | 11 | int:PSMD6 |
| Interaction | TXNIP interactions | 5.09e-05 | 212 | 160 | 9 | int:TXNIP | |
| Interaction | SOX2 interactions | TNPO1 MAGED1 COPA DSG3 POLM NANOG SPTAN1 UBR4 LARS1 CHD9 YTHDC2 EWSR1 TF IQGAP1 DHX15 KMT2C ZBTB7A KMT2D KIDINS220 HELZ2 EIF5B GNAI3 C5 BRSK1 CNOT1 SMG6 | 5.46e-05 | 1422 | 160 | 26 | int:SOX2 |
| Interaction | RUVBL1 interactions | TNPO1 DOCK8 STXBP5 NANOG ECD RNF149 NCBP1 EWSR1 LRRC59 HUWE1 VIRMA CREBBP IQGAP1 ZBTB7A KCNMA1 | 5.61e-05 | 575 | 160 | 15 | int:RUVBL1 |
| Interaction | LAMP1 interactions | CDC42EP4 SPTAN1 UBR4 PAK4 RNF149 EWSR1 LRRC59 HUWE1 ITGAV VIRMA IQGAP1 PTPN13 KIDINS220 PIPSL ADGRL2 CDK7 | 5.62e-05 | 644 | 160 | 16 | int:LAMP1 |
| Interaction | YWHAH interactions | CDC42EP4 SPTAN1 PAK4 NELFB GRB10 MPDZ HUWE1 VIRMA CREBBP TESPA1 IQGAP1 PTPN13 SYNJ2 PHF3 KCNMA1 AGFG1 GNAI3 HERC1 DNMBP WWC1 TNS3 CDK7 | 6.15e-05 | 1102 | 160 | 22 | int:YWHAH |
| Interaction | GARS1 interactions | 6.16e-05 | 270 | 160 | 10 | int:GARS1 | |
| Interaction | STX6 interactions | STXBP5 SPTAN1 PAK4 RNF149 LRRC59 RABL6 PTPN13 KIDINS220 STXBP6 AGFG1 PPP1R37 GNAI3 ADGRL2 | 6.18e-05 | 448 | 160 | 13 | int:STX6 |
| Interaction | SMARCAL1 interactions | 6.25e-05 | 53 | 160 | 5 | int:SMARCAL1 | |
| Interaction | KIF23 interactions | FLNB COPA SPTAN1 NOL6 LARS1 CHD9 NCBP1 YTHDC2 LRRC59 HUWE1 VIRMA IQGAP1 DHX15 DES FASN EXOC3L4 TADA2B EIF5B GNAI3 PIPSL SYNCRIP | 6.91e-05 | 1031 | 160 | 21 | int:KIF23 |
| Interaction | DDX20 interactions | 7.78e-05 | 224 | 160 | 9 | int:DDX20 | |
| Interaction | SNRNP200 interactions | TNPO1 ECD UBR4 EWSR1 LRRC59 HUWE1 VIRMA CREBBP CRY2 DHX15 SART1 ZGPAT SYNCRIP | 8.07e-05 | 460 | 160 | 13 | int:SNRNP200 |
| Interaction | UBE2A interactions | 8.33e-05 | 226 | 160 | 9 | int:UBE2A | |
| Interaction | ITGB1 interactions | FLNB SPTAN1 UBR4 CHD9 LRRC59 HUWE1 ITGA9 ITGAV VIRMA IQGAP1 FASN UNK | 8.72e-05 | 400 | 160 | 12 | int:ITGB1 |
| Interaction | PPARA interactions | 9.26e-05 | 92 | 160 | 6 | int:PPARA | |
| Interaction | POLR2A interactions | NANOG NELFB E2F3 RELA EWSR1 HUWE1 VIRMA CREBBP KMT2D CIITA UNK CNOT1 MED13 CDK7 | 9.88e-05 | 536 | 160 | 14 | int:POLR2A |
| Interaction | MTNR1B interactions | 1.03e-04 | 135 | 160 | 7 | int:MTNR1B | |
| Interaction | PINK1 interactions | FLNB MAGED1 DSG3 SPTAN1 ECD LARS1 PM20D1 HUWE1 TF IQGAP1 DHX15 SART1 S100A7A FASN EIF5B SYNCRIP | 1.04e-04 | 679 | 160 | 16 | int:PINK1 |
| Interaction | S100A2 interactions | FLNB BRSK2 GRB10 FAAP100 IQGAP1 DHX15 FASN KMT2D PTPN13 GCAT PPP1R37 BRSK1 | 1.15e-04 | 412 | 160 | 12 | int:S100A2 |
| Interaction | SOX9 interactions | 1.24e-04 | 97 | 160 | 6 | int:SOX9 | |
| Interaction | YWHAG interactions | RIPOR2 SPTAN1 PAK4 NELFB GRB10 MPDZ EWSR1 HUWE1 VIRMA TESPA1 IQGAP1 DHX15 PTPN13 SYNJ2 PHF3 KCNMA1 AGFG1 UNK DNMBP ZMYM3 WWC1 TNS3 CDK7 | 1.37e-04 | 1248 | 160 | 23 | int:YWHAG |
| Interaction | HDAC6 interactions | FLNB RIPOR2 COPA SPTAN1 RELA EWSR1 LRRC59 NR4A1 VIRMA NLRP3 IQGAP1 DHX15 PLCD3 DES FASN EIF5B GNAI3 ZMYM3 SYNCRIP | 1.49e-04 | 929 | 160 | 19 | int:HDAC6 |
| Interaction | YWHAE interactions | COPA DOCK8 SPTAN1 PAK4 LARS1 BRSK2 NELFB GRB10 NCBP1 EWSR1 HUWE1 VIRMA TESPA1 IQGAP1 CRY2 PTPN13 SYNJ2 KCNMA1 UNK BRSK1 DNMBP WWC1 CDK7 | 1.51e-04 | 1256 | 160 | 23 | int:YWHAE |
| Interaction | NCOA6 interactions | 1.61e-04 | 145 | 160 | 7 | int:NCOA6 | |
| Interaction | RHOJ interactions | CDC42EP4 DOCK8 SPTAN1 PAK4 BRSK2 ADGRL1 CACHD1 ITGAV IQGAP1 PTPN13 KIDINS220 AGFG1 EIF5B GNAI3 ADGRL2 | 1.62e-04 | 633 | 160 | 15 | int:RHOJ |
| Interaction | CNOT1 interactions | 1.68e-04 | 305 | 160 | 10 | int:CNOT1 | |
| Interaction | TSC22D2 interactions | 1.79e-04 | 66 | 160 | 5 | int:TSC22D2 | |
| Interaction | RANBP1P1 interactions | 1.87e-04 | 3 | 160 | 2 | int:RANBP1P1 | |
| Interaction | LILRB5 interactions | 1.87e-04 | 3 | 160 | 2 | int:LILRB5 | |
| Interaction | OBP2B interactions | 1.87e-04 | 3 | 160 | 2 | int:OBP2B | |
| Interaction | HSPA9 interactions | FLNB GINS3 NANOG LARS1 NELFB GRB10 NCBP1 HUWE1 NR4A1 VIRMA DHX15 SART1 FASN KCNMA1 UNK CDK7 | 2.27e-04 | 727 | 160 | 16 | int:HSPA9 |
| Interaction | ABL1 interactions | 2.32e-04 | 259 | 160 | 9 | int:ABL1 | |
| Interaction | PTOV1 interactions | 2.37e-04 | 70 | 160 | 5 | int:PTOV1 | |
| Interaction | TRIP4 interactions | 2.46e-04 | 206 | 160 | 8 | int:TRIP4 | |
| Interaction | MED1 interactions | 2.46e-04 | 206 | 160 | 8 | int:MED1 | |
| Interaction | STX7 interactions | CDC42EP4 STXBP5 SPTAN1 PAK4 RNF149 LRRC59 CACHD1 RABL6 KIDINS220 STXBP6 AGFG1 PPP1R37 ADGRL2 CREB3 CDK7 | 2.51e-04 | 659 | 160 | 15 | int:STX7 |
| Interaction | DIRAS3 interactions | SPTAN1 PAK4 LRRC59 CACHD1 HUWE1 PTPN13 KIDINS220 HERC1 ADGRL2 | 2.53e-04 | 262 | 160 | 9 | int:DIRAS3 |
| Interaction | GLDC interactions | 2.53e-04 | 321 | 160 | 10 | int:GLDC | |
| Interaction | SNRPB interactions | COPA NANOG NCBP1 EWSR1 HUWE1 VIRMA NLRP3 DHX15 SART1 ZGPAT FASN PHF3 SYNCRIP | 2.55e-04 | 517 | 160 | 13 | int:SNRPB |
| Interaction | KCTD13 interactions | FLNB MAGED1 COPA DOCK8 SPTAN1 LARS1 BRSK2 ADGRL1 OPA3 YTHDC2 EWSR1 LRRC59 VIRMA TF IQGAP1 DHX15 FASN KIDINS220 MAP1S BRSK1 CNOT1 SNTA1 CACNA2D3 SYNCRIP | 2.70e-04 | 1394 | 160 | 24 | int:KCTD13 |
| Interaction | PTPRM interactions | 2.70e-04 | 72 | 160 | 5 | int:PTPRM | |
| Interaction | SUMO2 interactions | FLNB COPA SPTAN1 UBR4 LARS1 EWSR1 HUWE1 IQGAP1 SART1 FASN PHF3 ZMYM3 SYNCRIP CDK7 | 2.71e-04 | 591 | 160 | 14 | int:SUMO2 |
| Interaction | S100A9 interactions | 2.75e-04 | 265 | 160 | 9 | int:S100A9 | |
| Interaction | BRAF interactions | 2.99e-04 | 212 | 160 | 8 | int:BRAF | |
| Interaction | PCBP1 interactions | NCBP1 EWSR1 HUWE1 VIRMA IQGAP1 CRY2 DHX15 SART1 ARHGAP4 DES FASN PHF3 UNK SYNCRIP CDK7 | 3.04e-04 | 671 | 160 | 15 | int:PCBP1 |
| Interaction | MAML2 interactions | 3.08e-04 | 17 | 160 | 3 | int:MAML2 | |
| Interaction | CNGA1 interactions | 3.08e-04 | 17 | 160 | 3 | int:CNGA1 | |
| Interaction | DUX4 interactions | 3.18e-04 | 214 | 160 | 8 | int:DUX4 | |
| Interaction | PRDX4 interactions | 3.18e-04 | 214 | 160 | 8 | int:PRDX4 | |
| Interaction | PSMD12 interactions | 3.23e-04 | 331 | 160 | 10 | int:PSMD12 | |
| Interaction | CSNK1G1 interactions | 3.39e-04 | 42 | 160 | 4 | int:CSNK1G1 | |
| Interaction | GSK3A interactions | ECD MPDZ YTHDC2 EWSR1 DHX15 SART1 PTPN13 KIDINS220 UNK BRSK1 WWC1 TNS3 | 3.43e-04 | 464 | 160 | 12 | int:GSK3A |
| Interaction | FMR1 interactions | MAGED1 UBR4 NCBP1 EWSR1 VIRMA IQGAP1 KCNMA1 LRP1 UNK BRSK1 CNOT1 SYNCRIP SMG6 | 3.60e-04 | 536 | 160 | 13 | int:FMR1 |
| Interaction | HSF1 interactions | COPA NOL6 LARS1 NCBP1 RELA EWSR1 LRRC59 RNF17 CREBBP DHX15 FASN EIF5B BRSK1 SYNCRIP | 3.66e-04 | 609 | 160 | 14 | int:HSF1 |
| Interaction | MCAM interactions | CDC42EP4 STXBP5 PAK4 ITGAV VIRMA IQGAP1 PTPN13 KIDINS220 GYPC DAAM2 GNAI3 PLSCR3 | 3.70e-04 | 468 | 160 | 12 | int:MCAM |
| Interaction | TPI1P1 interactions | 3.72e-04 | 4 | 160 | 2 | int:TPI1P1 | |
| Interaction | ZMIZ1 interactions | 4.06e-04 | 44 | 160 | 4 | int:ZMIZ1 | |
| Interaction | MAPK1 interactions | NANOG RNF149 GRB10 RELA HUWE1 NR4A1 ITGAV VIRMA CREBBP IQGAP1 CIITA PHF3 GNAI3 | 4.07e-04 | 543 | 160 | 13 | int:MAPK1 |
| Interaction | CDH1 interactions | FLNB CDC42EP4 SPTAN1 PAK4 PPP1R13B LRRC59 CREBBP IQGAP1 FASN KIDINS220 STXBP6 SYNJ2 AGFG1 PPP1R37 PLSCR3 ADGRL2 | 4.16e-04 | 768 | 160 | 16 | int:CDH1 |
| Interaction | CTNNB1 interactions | TCF7 COPA NANOG SPTAN1 LARS1 GRB10 PPP1R13B MPDZ RELA EWSR1 HUWE1 NR4A1 VIRMA CREBBP IQGAP1 KMT2D PTPN13 UNK SYNCRIP | 4.21e-04 | 1009 | 160 | 19 | int:CTNNB1 |
| Interaction | PGRMC2 interactions | 4.22e-04 | 281 | 160 | 9 | int:PGRMC2 | |
| Interaction | YAP1 interactions | FLNB COPA SPTAN1 MPDZ RELA LRRC59 HUWE1 CREBBP IQGAP1 DHX15 KMT2C FASN KMT2D PTPN13 PHF3 UNK GNAI3 CNOT1 WWC1 SYNCRIP | 4.36e-04 | 1095 | 160 | 20 | int:YAP1 |
| Interaction | MED14 interactions | 4.40e-04 | 171 | 160 | 7 | int:MED14 | |
| Interaction | KPNA4 interactions | 4.45e-04 | 225 | 160 | 8 | int:KPNA4 | |
| Interaction | PML interactions | MAGED1 NANOG KLHL40 NCBP1 E2F3 RELA NR4A1 CREBBP DHX15 SART1 PPARGC1A FASN MAP1S CIITA PHF3 ZMYM3 SYNCRIP CDK7 | 4.52e-04 | 933 | 160 | 18 | int:PML |
| Interaction | AGR2 interactions | FLNB COPA SPTAN1 UBR4 LARS1 NCBP1 PSMD5 EWSR1 LRRC59 HUWE1 IQGAP1 DHX15 FASN EIF5B DAAM2 BRSK1 CNOT1 SYNCRIP | 4.58e-04 | 934 | 160 | 18 | int:AGR2 |
| Interaction | CTNNA1 interactions | SPTAN1 ECD GRB10 PPP1R13B VIRMA ZGPAT FASN PTPN13 KIDINS220 UNK | 4.68e-04 | 347 | 160 | 10 | int:CTNNA1 |
| Interaction | CALR interactions | COPA EWSR1 LRRC59 HUWE1 ITGAV VIRMA TF KMT2C KCNMA1 LRP1 PPP1R37 | 4.84e-04 | 414 | 160 | 11 | int:CALR |
| Interaction | PPP1R13B interactions | 5.23e-04 | 176 | 160 | 7 | int:PPP1R13B | |
| Interaction | BAK1 interactions | 5.23e-04 | 47 | 160 | 4 | int:BAK1 | |
| Interaction | METTL14 interactions | COPA SPTAN1 LARS1 NCBP1 EWSR1 LRRC59 HUWE1 VIRMA IQGAP1 GNAI3 HERC1 SYNCRIP SMG6 | 5.26e-04 | 558 | 160 | 13 | int:METTL14 |
| Interaction | SF3B3 interactions | COPA SPTAN1 EWSR1 HUWE1 VIRMA DHX15 PLCD3 SART1 FASN MAP1S TADA2B UNK SYNCRIP | 5.26e-04 | 558 | 160 | 13 | int:SF3B3 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 1.88e-04 | 4 | 102 | 2 | 918 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TCF7 RIPOR2 DOCK8 SPTAN1 UBR4 SERTAD2 RNF149 IFI44 YTHDC2 DENND1C HUWE1 CREBBP TESPA1 IQGAP1 ARHGAP4 KMT2C KMT2D KIDINS220 PHF3 GYPC SEL1L3 AGFG1 GNAI3 HERC1 CNOT1 MED13 | 2.58e-06 | 1492 | 166 | 26 | M40023 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 3.04e-06 | 139 | 166 | 8 | M8948 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | AMT RIPOR2 CDC42EP4 POLM SPTAN1 UBR4 NOL6 DENND1C ATG2A RAX2 FAAP100 CREBBP CDAN1 ARHGAP4 HELZ2 UNK PLSCR3 CARNS1 ALOX5 | 5.03e-06 | 905 | 166 | 19 | M40865 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 MAGED1 ECD SERTAD2 CHD9 CREBBP SART1 KMT2C GYPC LRP1 PPP1R37 WWC1 SMG6 | 9.41e-06 | 467 | 166 | 13 | M1347 |
| Coexpression | GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.29e-05 | 169 | 166 | 8 | M9087 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 MAGED1 ECD SERTAD2 CHD9 CREBBP SART1 KMT2C GYPC LRP1 PPP1R37 WWC1 SMG6 | 1.37e-05 | 484 | 166 | 13 | MM999 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.03e-05 | 180 | 166 | 8 | M8239 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 4.15e-05 | 199 | 166 | 8 | M9501 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 4.30e-05 | 200 | 166 | 8 | M4788 | |
| Coexpression | PILON_KLF1_TARGETS_UP | GINS3 MAGED1 CYP2D7 CYP2D6 GRB10 HUWE1 TF PLEK2 TADA2B AGFG1 C5 MED13 WWC1 | 4.36e-05 | 541 | 166 | 13 | MM1061 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | RIPOR2 PRAMEF5 GRB10 GRIN2C RNF17 ESRP2 DES ESYT3 GYPC HHAT GUCY2D PRAMEF6 ADSS1 | 7.93e-05 | 574 | 166 | 13 | MM820 |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 5.92e-07 | 191 | 165 | 8 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.92e-07 | 191 | 165 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.18e-07 | 82 | 165 | 6 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.18e-07 | 82 | 165 | 6 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.18e-07 | 82 | 165 | 6 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.19e-07 | 196 | 165 | 8 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.19e-06 | 159 | 165 | 7 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 174 | 165 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-06 | 174 | 165 | 7 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 191 | 165 | 7 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 191 | 165 | 7 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 7.34e-06 | 191 | 165 | 7 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.60e-06 | 192 | 165 | 7 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.60e-06 | 192 | 165 | 7 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 7.60e-06 | 192 | 165 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.60e-06 | 192 | 165 | 7 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 7.60e-06 | 192 | 165 | 7 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-06 | 193 | 165 | 7 | 2b80991e7ba7640f7ab2139d30e4c54d8e533862 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 7.86e-06 | 193 | 165 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-06 | 193 | 165 | 7 | 90cfc34c2d0d7c70f071703d35db1d6037961481 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 8.13e-06 | 194 | 165 | 7 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 8.41e-06 | 195 | 165 | 7 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 195 | 165 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 8.41e-06 | 195 | 165 | 7 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.69e-06 | 196 | 165 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.69e-06 | 196 | 165 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.98e-06 | 197 | 165 | 7 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.98e-06 | 197 | 165 | 7 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 9.28e-06 | 198 | 165 | 7 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-06 | 199 | 165 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 165 | 7 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.91e-06 | 200 | 165 | 7 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.91e-06 | 200 | 165 | 7 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 134 | 165 | 6 | a632d78890fcc20db81d2cf6b299470706d2e182 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 134 | 165 | 6 | 8be2db71d9d29f9a57a64efdc89cf8c3e32b363b | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-05 | 146 | 165 | 6 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 154 | 165 | 6 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 158 | 165 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 158 | 165 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 162 | 165 | 6 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 162 | 165 | 6 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 3.63e-05 | 166 | 165 | 6 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 169 | 165 | 6 | 91cfff1ad559cc327c6bb71c98aa29f0b3642568 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 169 | 165 | 6 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 169 | 165 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 169 | 165 | 6 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 4.43e-05 | 172 | 165 | 6 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.87e-05 | 175 | 165 | 6 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-05 | 177 | 165 | 6 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 179 | 165 | 6 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-05 | 179 | 165 | 6 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 5.70e-05 | 180 | 165 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-05 | 181 | 165 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-05 | 181 | 165 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 5.88e-05 | 181 | 165 | 6 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.06e-05 | 182 | 165 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-05 | 182 | 165 | 6 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 182 | 165 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.06e-05 | 182 | 165 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-05 | 182 | 165 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-05 | 182 | 165 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.24e-05 | 183 | 165 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-05 | 183 | 165 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-05 | 183 | 165 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.63e-05 | 185 | 165 | 6 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.63e-05 | 185 | 165 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.83e-05 | 186 | 165 | 6 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 186 | 165 | 6 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.83e-05 | 186 | 165 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 186 | 165 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-05 | 187 | 165 | 6 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 189 | 165 | 6 | 5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 189 | 165 | 6 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 189 | 165 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.68e-05 | 190 | 165 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 165 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 165 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 7.91e-05 | 191 | 165 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 7.91e-05 | 191 | 165 | 6 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 119 | 165 | 5 | 79342c491a214c870ff6215da613db4a28c9d587 | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 119 | 165 | 5 | 36857095d4e4cc6428d13bf7de04daec1f4cde1e | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 8.14e-05 | 192 | 165 | 6 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 8.37e-05 | 193 | 165 | 6 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.37e-05 | 193 | 165 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 8.37e-05 | 193 | 165 | 6 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 193 | 165 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 193 | 165 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-05 | 194 | 165 | 6 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 194 | 165 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.86e-05 | 195 | 165 | 6 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-05 | 195 | 165 | 6 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.86e-05 | 195 | 165 | 6 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.86e-05 | 195 | 165 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| Drug | phenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA | GINS3 TCF7 ZBTB7A KIDINS220 GCAT KCNJ3 PLSCR3 ADGRL2 WWC1 SYNCRIP | 1.42e-06 | 194 | 163 | 10 | 1115_DN |
| Drug | sodium linoleate | CYP2D7 CYP2D6 PSMD5 RELA TF PPARGC1A FASN CPT1C GYPC KCNMA1 LRP1 ALOX5 | 6.95e-06 | 342 | 163 | 12 | CID000003931 |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.76e-06 | 185 | 163 | 9 | 1049_DN | |
| Disease | X-21358 measurement | 2.89e-05 | 2 | 159 | 2 | EFO_0022120 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 8.63e-05 | 3 | 159 | 2 | EFO_0803063 | |
| Disease | solanidine measurement | 1.72e-04 | 4 | 159 | 2 | EFO_0800966 | |
| Disease | odorant-binding protein 2b measurement | 2.85e-04 | 5 | 159 | 2 | EFO_0801859 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 2.86e-04 | 24 | 159 | 3 | EFO_0003761, EFO_0005658 | |
| Disease | Sezary Syndrome | 4.08e-04 | 27 | 159 | 3 | C0036920 | |
| Disease | serum non-albumin protein measurement | 7.94e-04 | 361 | 159 | 8 | EFO_0004568 | |
| Disease | emphysema | 8.85e-04 | 35 | 159 | 3 | EFO_0000464 | |
| Disease | response to tamoxifen | 1.01e-03 | 9 | 159 | 2 | EFO_0009391 | |
| Disease | molar-incisor hypomineralization | 1.01e-03 | 9 | 159 | 2 | EFO_0005321 | |
| Disease | neutrophil count | FLNB RIPOR2 COPA DOCK8 OLFML2B STXBP5 CHD9 VWA7 CREBBP NLRP3 ZGPAT KIDINS220 STXBP6 TADA2B ADGRL2 TNS3 SMG6 | 1.32e-03 | 1382 | 159 | 17 | EFO_0004833 |
| Disease | serum gamma-glutamyl transferase measurement | TNPO1 OBP2B SERTAD2 CHD9 ITGA9 FAAP100 MAP1S SYNJ2 N6AMT1 EXOC3L4 ADGRL2 DNMBP MED13 | 1.40e-03 | 914 | 159 | 13 | EFO_0004532 |
| Disease | Carcinoma, Transitional Cell | 1.41e-03 | 41 | 159 | 3 | C0007138 | |
| Disease | colon cancer (implicated_via_orthology) | 1.54e-03 | 11 | 159 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.63e-03 | 93 | 159 | 4 | C1535926 | |
| Disease | Squamous cell carcinoma of esophagus | 1.77e-03 | 95 | 159 | 4 | C0279626 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.85e-03 | 45 | 159 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | bilirubin measurement | 2.83e-03 | 442 | 159 | 8 | EFO_0004570 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.89e-03 | 15 | 159 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.89e-03 | 15 | 159 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.89e-03 | 15 | 159 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079758 | |
| Disease | Cannabis use | 3.29e-03 | 16 | 159 | 2 | EFO_0007585 | |
| Disease | respiratory symptom change measurement, response to placebo | 3.72e-03 | 17 | 159 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | aspartate aminotransferase measurement | TNPO1 ZNF704 FLNB OBP2B FSTL4 ITGA9 NLRP3 DHX15 ZGPAT PPARGC1A DNMBP SMG6 | 3.73e-03 | 904 | 159 | 12 | EFO_0004736 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.81e-03 | 63 | 159 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Lymphoma, Follicular | 5.14e-03 | 20 | 159 | 2 | C0024301 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.16e-03 | 128 | 159 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C0007134 | |
| Disease | monocyte count | TNPO1 FLNB DOCK8 STXBP5 SERTAD2 PM20D1 DENND1C VWA7 S100A7A STXBP6 CIITA TADA2B EXOC3L1 TNS3 SMG6 | 5.26e-03 | 1320 | 159 | 15 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLLDSELLADASFGL | 216 | Q8N944 | |
| QGLNDSVTLDDLADF | 366 | Q01844 | |
| LDLLFEALGQAVEAA | 191 | Q86VI1 | |
| LDSDGVDAAALAELA | 201 | Q17RC7 | |
| ELLDEGSDFFDSLLQ | 676 | Q86US8 | |
| FDLADISLNIEGGDL | 736 | A0FGR9 | |
| QDGDAGFLLSLLEQE | 61 | A6NDY0 | |
| LILDGFEELEAQDGF | 496 | P33076 | |
| LLDVLEEGAFLLADN | 651 | O94910 | |
| GQDAAFTAILDTLDI | 201 | P15085 | |
| VLALADDGASVLFEA | 236 | Q8WXK1 | |
| GSLFDLENDLPDELI | 31 | Q92793 | |
| LGAGAEADFSILDEA | 31 | Q5VU97 | |
| AEAALAAVLALEAGL | 296 | A5YM72 | |
| LDTLEEGAFVLADNL | 641 | O95490 | |
| FNAAQDLDVSLLEGD | 1296 | Q6XZF7 | |
| LAALNDDGDLTELGS | 546 | O43143 | |
| LDSSFLGSGEELDLL | 546 | Q8IV53 | |
| GDFAEELATLSNLFL | 1186 | Q8IWY9 | |
| DNDGEFLLIEAADFL | 111 | O95905 | |
| LLLDASLEGEFDLVQ | 891 | Q96KQ4 | |
| LDLANFQADVELGAL | 586 | Q2TAZ0 | |
| LSEALEILAEAAGFE | 156 | Q9NP87 | |
| FSALANIDLALEQGD | 306 | P46940 | |
| NIDLALEQGDALALF | 311 | P46940 | |
| ADGFALEEASLRLLA | 156 | Q96IS3 | |
| LKNDSDLFGLGLEEA | 621 | Q3YEC7 | |
| GFAELSPADQDLLLE | 426 | P22736 | |
| QLAFIVDEGGFILDD | 211 | Q6GTS8 | |
| SLEEGGEFDDLVSAL | 1016 | Q86T65 | |
| FIADDLDDSFLDSLG | 836 | P32926 | |
| LNFSFEELNTLGLDE | 1326 | Q9ULH0 | |
| NDPNLDDLLRSGEFD | 2741 | Q8NEZ4 | |
| GEDEAELALSLLAQL | 351 | Q66K74 | |
| LLGFQAEASVEDSAL | 11 | Q9Y5V3 | |
| AQLALLDGPFADLGD | 1101 | Q12791 | |
| LAFELFAEEQAEGPN | 411 | Q643R3 | |
| LESNLEGLAGVLEAD | 46 | Q09161 | |
| ADDARQLFVLAGSAE | 101 | P08754 | |
| EAAEELGLTDGSLVF | 261 | Q02846 | |
| LAGDAFLNSLEFEDP | 556 | Q8IX03 | |
| DGNELDLSLSDLNEV | 16 | Q96AG4 | |
| PDDVGGLLDADFALD | 4481 | Q07954 | |
| LTFDDQFLLTAAEDG | 646 | Q96MR6 | |
| AAGELIAAFQLIELD | 881 | A9Z1Z3 | |
| EEEFELLAGPLGLND | 3091 | Q15751 | |
| LFALLVGALPFDDDN | 206 | Q8IWQ3 | |
| LDLSDNGFDSDLLTL | 486 | Q8ND23 | |
| AIEALKEFNEDGALA | 61 | O60506 | |
| GSAADFLLDISETDL | 1921 | O75369 | |
| EALTDADDFGLQFPL | 246 | Q9NRY6 | |
| ADDFGLQFPLDLDVR | 251 | Q9NRY6 | |
| LNEEAAAELGAELLG | 71 | Q9H6K4 | |
| LLGEGFADESLDLVA | 866 | Q9H6R4 | |
| ALAQDVTGALEDALA | 456 | Q96MW5 | |
| SLLEEFLGNDFDLGA | 31 | Q96LU7 | |
| SDLEAALEAAGEGLN | 261 | Q9H9S0 | |
| TGNLALLADEFALED | 466 | Q8WX92 | |
| DADFLGLSADELIAI | 166 | Q2TBA0 | |
| DANAGLFEALLTPED | 136 | O75600 | |
| GLAAALSFTLEEEDI | 11 | Q9NY56 | |
| EDALFGLLFGADATL | 221 | Q0VG06 | |
| DLLDRFDGILADAGQ | 56 | Q7Z6Z7 | |
| LDFLQDIPDGLFLDA | 231 | A2A3N6 | |
| QTSLADFILEGLFDD | 6 | Q8NHA4 | |
| LEQTNLDEDGASALF | 141 | O75864 | |
| LDVNDLDTDSFLGGL | 41 | Q9UBK2 | |
| LDQEFELETDTLFGG | 36 | Q5VTY9 | |
| LSLEAEENALPGFAE | 116 | Q9HAB8 | |
| LDDLDNDGFPDVAIG | 371 | Q13797 | |
| GLAAALSFTLEEEDI | 11 | Q9NPH6 | |
| IEDALLDVASLFQAG | 751 | Q8TCG5 | |
| DANLFGETLEGLSDD | 11 | Q3L8U1 | |
| GLNEADADFLDDLLS | 211 | Q14674 | |
| AADDFLEDLPFEQIG | 416 | Q8TCB0 | |
| LSLGEEEGISDLFDA | 436 | O00716 | |
| GLLFTELAAALDAEG | 1161 | Q8NF50 | |
| PANTLGNDFDLADAL | 111 | Q8TCZ2 | |
| DELLLDADFSVNAGS | 401 | Q49AN0 | |
| SILDTLGDDDFFNII | 281 | Q8IZS8 | |
| FSAAGDDLLDLIQGL | 261 | P50613 | |
| LDLAQEGLKEESGFL | 206 | P10635 | |
| LQLDEDGFVEATEGL | 851 | P53621 | |
| LANLDEFAEDIFLNG | 1661 | P01031 | |
| GLTLNFLDLEDINDF | 286 | Q6MZW2 | |
| PLGDLDQDGFNDIAI | 376 | P06756 | |
| TLDELLAAGEAGTFD | 166 | Q86VU5 | |
| GELLDFSLADAVNQE | 86 | P17661 | |
| DPLLDEQAFGDLTDL | 176 | Q9H3Q1 | |
| LFALLVGALPFDDDN | 221 | Q8TDC3 | |
| LADLEDSNIFSLIAG | 336 | Q13322 | |
| FAESADAALQGDPAL | 101 | P04921 | |
| LSLFTNEAGGILDDL | 116 | P48728 | |
| AFAGDEVLVQLLSGD | 1166 | Q9BYK8 | |
| AAVNLDSSLADLGLD | 2141 | P49327 | |
| DDLLSGDLIFLGSDS | 241 | O95377 | |
| FEDAALEENGLAVIG | 41 | Q8WTZ4 | |
| DAGDQDLLAFLLEES | 6 | O43889 | |
| DFSEFLSLLGDIAAD | 71 | Q86SG5 | |
| DIFDINEGLGLDLFE | 36 | Q16820 | |
| EALAALEAATAGEDL | 296 | Q8IY42 | |
| DSFLGDSELIGDLTQ | 136 | Q9BT04 | |
| GLISQDLDFDISDLV | 2426 | Q12923 | |
| GAKDGALTLLLDEFE | 76 | O96013 | |
| VELDLSDNALGDFGI | 801 | Q96P20 | |
| FLAGFPVLDANDLED | 11 | Q14802 | |
| LFQLELEVVDGDGAA | 401 | P0C091 | |
| ISLLLSEVNGFADDL | 281 | A8MW99 | |
| DGDSQGFFNLALLIE | 981 | Q68CR1 | |
| LVEGANAALLDIDFG | 251 | Q8N142 | |
| LAADQTEALFVGDAI | 121 | Q13424 | |
| NALLFAEEEDGEAGA | 401 | O15240 | |
| GALGPEENFLSLDDI | 11 | Q9BRX5 | |
| TAGELNLLDSDLDVD | 816 | O15056 | |
| DSEFAAIENLPGFEL | 336 | Q86TJ2 | |
| DFELLDGIDANKTDP | 286 | P09917 | |
| LQNVLDLDGDPELFE | 486 | Q17RQ9 | |
| LALADAGDTVEDANF | 741 | Q9P2J5 | |
| SDLEAALEAAGEGLN | 261 | Q6NSW7 | |
| GVEEENFEGLSLSAL | 136 | O95744 | |
| DIDLDALAAEIEGAG | 16 | O60841 | |
| AEDLEQLGGLLAAAA | 171 | B7ZBB8 | |
| ATIEDILSFLGEAAA | 486 | Q9H6T0 | |
| NNSGLFLEDELDIIG | 1136 | Q9UHV7 | |
| EKAELDQLLSGFGLE | 421 | Q68CZ2 | |
| FSGDNGVDLLIEDQL | 321 | Q68BL8 | |
| FLINEGALVSALADD | 106 | Q5T5C0 | |
| DLFGELLASSELEAT | 596 | P98171 | |
| DGSLEDAFNGLLLAL | 601 | Q9Y4F9 | |
| AESLENFLGLETDLQ | 496 | Q9C0B6 | |
| FLEAQGDLLETQGDL | 336 | Q0P6D6 | |
| QFDLLSDLGSDIFAA | 196 | P52594 | |
| EVLELLDNGAGADSF | 641 | Q14CN2 | |
| VEGLLDATSGADADL | 1666 | A5YKK6 | |
| LDLAQEGLKEESGFL | 206 | A0A087X1C5 | |
| EDNVLLVELFDSLGA | 831 | Q9BXT8 | |
| EAFQAVLDGLDALLT | 76 | Q5VXH4 | |
| AANLSLALPDDDGSD | 341 | Q8NC42 | |
| SGDLAEQFLDDSTAL | 206 | Q9NYT0 | |
| IDPNGDSAEFDLLFE | 91 | Q8NFX7 | |
| IAANEADAVTLDAGL | 71 | P02787 | |
| FRADLALVGTNDADL | 821 | O75970 | |
| GFLTDLTLDDILFAD | 236 | Q14140 | |
| DADEELLFNIPFTGN | 71 | Q9GZP4 | |
| LEFLEDQGEEGATLA | 276 | Q8N3E9 | |
| ADELASDVAGAEALL | 386 | Q13813 | |
| QEAFLLNEDLGDSLD | 486 | Q13813 | |
| LNEDLGDSLDSVEAL | 491 | Q13813 | |
| EAFQAVLDGLDALLT | 76 | Q5TYX0 | |
| LDDALFLGSNLENEV | 16 | Q92576 | |
| DDLLPLGDQTQDGDF | 421 | O43290 | |
| DLGAPDELLAFQDEG | 16 | P36402 | |
| IDSFIENLFALAGDE | 221 | Q92973 | |
| GIDEAEASNLLFDEP | 166 | Q6ZNC4 | |
| LLDDGGDAVFSQLTE | 441 | Q9H6S0 | |
| QAGLEALFESNLLDD | 156 | Q16401 | |
| DDLTLGAEATLLAAN | 96 | A2RU30 | |
| QGEAGQLEEAFSLAL | 166 | Q9Y4F4 | |
| SDEGIGTLAENLLEA | 4756 | Q5T4S7 | |
| ESALDDLDLNEFGVA | 516 | Q9C0B0 | |
| LQLQFDDEDLGALLG | 441 | Q04206 | |
| DFLGRTLLADDLFAA | 76 | Q9Y334 | |
| DDDNLDSLLDSVVGL | 1466 | Q69YN4 | |
| ELALGAGLDSSEQAD | 21 | Q8N5A5 | |
| ANVLDEPGQDLEADF | 986 | Q14202 | |
| ILAADAGADAGQLDL | 131 | O95365 | |
| PHLDDLLNGDEFDLL | 3036 | O14686 | |
| LDQLELDVGFSTGAD | 246 | P48549 | |
| LGGIADEAFEDFLLT | 136 | Q9ULH4 | |
| LLLDALEAAAAELAG | 31 | Q9Y5N5 | |
| EEAEVLFAEAAQAGL | 231 | Q14957 |